相关实验视频

Updated: May 20, 2025

Chronic Thromboembolic Pulmonary Hypertension and Assessment of Right Ventricular Function in the Piglet

Chronic Thromboembolic Pulmonary Hypertension and Assessment of Right Ventricular Function in the Piglet

Published on: November 4, 2015

慢性血栓栓塞性肺高血压慢性血栓塞性肺高血压

John-Peder Escobar Kvitting¹, Håvard Ravnestad², Rune Andersen³

¹Thoraxkirurgisk avdeling, Oslo universitetssykehus, Rikshospitalet, og, Institutt for klinisk medisin, Universitetet i Oslo.

Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke

|March 27, 2025

概括

慢性血栓栓塞性肺高血压 (CTEPH) 是一种严重的疾病,通常是肺栓塞之后. 肺内关节切除术是主要的治疗方法,除了血管造形术和无法手术的患者的医疗选择.

科学领域:

心脏病学心脏病学
肺部医学肺部医学
血管外科血管外科

背景情况:

慢性血栓栓塞性肺高血压 (CTEPH) 是肺栓塞的一个罕见但严重的并发症.
CTEPH与显著的发病率和死亡率有关.
早期诊断和管理对于改善患者的治疗结果至关重要.

研究的目的:

提供CTEPH治疗的全面临床概述.
讨论当前的药理,内血管和外科手术治疗选择.
突出针对CTEPH患者量身定制的治疗策略的重要性.

主要方法:

审查关于CTEPH管理的当前文献.
对肺内关节切除术,气球肺血管造形术和医疗疗法的治疗结果的分析.
治疗选择的临床指南综合.

主要成果:

肺内关节切除术是黄金标准,提供潜在的治疗和改善血液动力学和运动能力.
穿皮气球肺血管整形术是不可手术患者的可行的替代方案.
医学疗法在特定情况下提供症状缓解和血液动力学改善.

结论:

对CTEPH的治疗决定应根据患者的可操作性和疾病特征进行个性化.
多学科的方法对于CTEPH的最佳管理至关重要.
持续的研究对于推进CTEPH治疗方式至关重要.

更多相关视频

Induction and Phenotyping of Acute Right Heart Failure in a Large Animal Model of Chronic Thromboembolic Pulmonary Hypertension

Induction and Phenotyping of Acute Right Heart Failure in a Large Animal Model of Chronic Thromboembolic Pulmonary Hypertension

Published on: March 17, 2022

Left Atrial Stenosis Induced Pulmonary Venous Arterialization and Group 2 Pulmonary Hypertension in Rat

Left Atrial Stenosis Induced Pulmonary Venous Arterialization and Group 2 Pulmonary Hypertension in Rat

Published on: November 18, 2018

相关概念视频

Pulmonary Hypertension: Classification and Pathogenesis

Pulmonary Hypertension: Classification and Pathogenesis

Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...

Chronic Obstructive Pulmonary Disease

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...

Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers

Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers

Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...

Chronic Obstructive Pulmonary Disease-I: Introduction

Chronic Obstructive Pulmonary Disease-I: Introduction

Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:

COPD: Pathogenesis and Clinical Features

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...